Sevelamer, a phosphate binder widely prescribed to manage hyperphosphatemia, presents a peculiar clinical paradox. Its process involves binding to dietary phosphate in the digestive tract , preventing its https://rajneesh-gulati361374.blog-gold.com/1096914/sevelamer-when-drug-resembles-disorder